Fentanyl Induces the Differentiation of Cancer Stem Cell and Apoptosis

Cancer stem cells are involved in the onset and development of cancer as well as in resistance to chemo and radiotherapy and also metastasis. Elimination of these cells or inducing to differentiation to normal cancer cells will be important in the treatment of cancer. There are some publications that report the positive effects of mu-opioid antagonists on cancer stem cell differentiation. Fentanyl is a mu-opioid analgesic that acts 80 times faster than morphine and is frequently used in cancer patients. In this study, we treated the pancreatic cancer cells, BxPC-3 with Fentanyl and compared the results with the untreated cell group. The number of stem cells in the untreated group was 6.2%, but this rate decreased to 2% in the Fentanil treated group. In order to understand whether this is due to induction of cells due to apoptosis or induction of differentiation, we have evaluated the expressions of apoptosis markers Bad, Bax, Bcl-2 and p53, and stem cell markers Nanog, Oct4 and Sox2. Our results showed that Fentanyl induced both cell induction and cell differentiation in pancreatic cancer cells, BxPC-3.

Erişime Açık
Görüntülenme
3
22.03.2024 tarihinden bu yana
İndirme
1
22.03.2024 tarihinden bu yana
Son Erişim Tarihi
19 Nisan 2024 19:24
Google Kontrol
Tıklayınız
Tam Metin
Tam Metin İndirmek için tıklayın Ön izleme
Detaylı Görünüm
Eser Adı
(dc.title)
Fentanyl Induces the Differentiation of Cancer Stem Cell and Apoptosis
Yayın Türü
(dc.type)
Konferans Bildirisi
Yazar/lar
(dc.contributor.author)
YILDIRIM, İbrahim Halil
Yazar/lar
(dc.contributor.author)
DURAN, Tuğçe
Atıf Dizini
(dc.source.database)
Diğer
Konu Başlıkları
(dc.subject)
Cancer Stem Cell
Konu Başlıkları
(dc.subject)
Pancreatic Cancer
Konu Başlıkları
(dc.subject)
Bxpc-3
Konu Başlıkları
(dc.subject)
Apoptosis
Konu Başlıkları
(dc.subject)
Differentiation
Yayıncı
(dc.publisher)
6th International Multidisciplinary Studies Congress
Yayın Tarihi
(dc.date.issued)
2019
Kayıt Giriş Tarihi
(dc.date.accessioned)
2019-07-11T12:54:29Z
Açık Erişim tarihi
(dc.date.available)
2019-07-11T12:54:29Z
Özet
(dc.description.abstract)
Cancer stem cells are involved in the onset and development of cancer as well as in resistance to chemo and radiotherapy and also metastasis. Elimination of these cells or inducing to differentiation to normal cancer cells will be important in the treatment of cancer. There are some publications that report the positive effects of mu-opioid antagonists on cancer stem cell differentiation. Fentanyl is a mu-opioid analgesic that acts 80 times faster than morphine and is frequently used in cancer patients. In this study, we treated the pancreatic cancer cells, BxPC-3 with Fentanyl and compared the results with the untreated cell group. The number of stem cells in the untreated group was 6.2%, but this rate decreased to 2% in the Fentanil treated group. In order to understand whether this is due to induction of cells due to apoptosis or induction of differentiation, we have evaluated the expressions of apoptosis markers Bad, Bax, Bcl-2 and p53, and stem cell markers Nanog, Oct4 and Sox2. Our results showed that Fentanyl induced both cell induction and cell differentiation in pancreatic cancer cells, BxPC-3.
Yayın Dili
(dc.language.iso)
en
Tek Biçim Adres
(dc.identifier.uri)
https://hdl.handle.net/20.500.12498/1384
Analizler
Yayın Görüntülenme
Yayın Görüntülenme
Erişilen ülkeler
Erişilen şehirler
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve cerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms